Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Thrombotic Microangiopathy | Correction

Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema

Authors: Yawara Kikuchi, Yoshimi Odashima, Kazuhiro Yoshikawa, Tomoyasu Oda, Fumitaka Tanaka, Hiroki Oikawa, Yasushi Ishigaki, Koichi Asahi

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Excerpt

Correction: BMC Nephrol 23, 348 (2022)
Appendix
Available only for authorised users
Metadata
Title
Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Authors
Yawara Kikuchi
Yoshimi Odashima
Kazuhiro Yoshikawa
Tomoyasu Oda
Fumitaka Tanaka
Hiroki Oikawa
Yasushi Ishigaki
Koichi Asahi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03006-z

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.